Claroty equips pharma & biotech companies with the industrial cybersecurity controls needed to protect their OT, IoT, IIoT, and BMS assets and all other cyber-physical systems (CPS) against threats ranging from ransomware, to IP theft, and more.
The COVID-19 pandemic, widespread supply chain disruptions, frequent M&A activity, evolving regulatory and policy landscapes, and rising life expectancies are among the factors driving digital transformation for pharma & biotech companies. From new advancements that expedite vaccine production and distribution, to sensors that share real-time data across storage silos, processing tanks, and ERP platforms to optimize supply chain management, to robotic CIP and container handling systems that reduce resource waste and regulatory complexity while enhancing sanitation and safety — the benefits of automation, IT/OT connectivity, and cyber-physical systems (CPS) are why their once-manual, analog counterparts are becoming relics of the past.
However, for many pharma & biotech companies, these benefits are outpaced by industrial cybersecurity risks. This unfortunate reality has repeatedly manifested as ransomware and other cyber attacks that exploit security weaknesses in the CPS on which the availability, integrity, and safety of pharma & biotech operations and products rely. Mitigating these risks to, ultimately, gain cyber and operational resilience requires a new approach that extends far beyond traditional, IT-oriented security solutions.
Securing the OT environments that underpin pharma & biotech development, production, storage, packaging, and distribution operations requires that companies follow three key principles:
A comprehensive inventory of all OT, IoT, IIoT, and BMS assets — and all other CPS — that underpin your OT environment across each plant is the foundation of effective industrial cybersecurity. It’s also why Claroty has long prioritized our ability to deliver the industry-leading visibility that our pharma & biotech customers need to secure their most critical assets and operations.
Since most CPS use proprietary protocols and legacy systems, they are simply incompatible with traditional IT solutions — but that doesn’t mean they have no place in OT. Rather than urge customers to expand their already-extensive tech stacks, Claroty integrates with them. As a result, our pharma & biotech customers can simply extend their existing tools and workflows from IT to OT.
Unlike their IT counterparts, most OT environments lack essential cybersecurity controls and consistent governance. Claroty eliminates this gap. After providing visibility into all CPS and integrating your IT tools and workflows with OT, Claroty extends your IT controls to OT — unifying your security governance and driving all use cases on your journey to cyber and operational resilience.
The Claroty journey to cyber resilience empowers pharma & biotech companies to extend — and further optimize — the following cybersecurity use cases and governance areas from IT to OT:
Claroty’s automated asset discovery capabilities create a centralized inventory that serves as the foundation for all cyber resilience use cases, empowering pharma & biotech companies with real-time visibility into all OT, IoT, and BMS assets and all other CPS throughout your OT environment.
Claroty extends your IT vulnerability & risk management controls to OT by automatically identifying, assessing, and recommending remedial actions for all CPS vulnerabilities in your manufacturing environment, enabling you to prioritize and implement mitigations to minimize lateral risk transfer.
Claroty hardens the critical OT environments in pharma & biotech against threats by automatically defining network segmentation policies to be easily enforced by your firewall and NAC solutions, as well as providing secure remote access purpose-built with controls for internal and third-party OT users.
Claroty enables pharma & biotech companies to continuously monitor for and respond to the earliest indicators of threats — ranging from ransomware, to IP theft, to equipment failures, to malicious insiders — before they impact production, safety, sanitation, compliance, or other assets.
The Claroty journey to operational resilience empowers pharma & biotech companies to extend and optimize the following security and operational use cases and governance areas from your IT to OT environments:
Operational resilience requires full visibility into all CPS in your OT environment. Our automated asset discovery capabilities deliver just this — empowering pharma & biotech companies with the complete, real-time visibility you need as the foundation for all operational resilience use cases.
Change management is essential to governance, compliance, maintenance, and procurement decisions enterprise-wide. Claroty empowers MoC programs across IT and OT with continuous asset and operational monitoring and flexible reporting to inform these and related decisions.
Claroty helps pharma & biotech companies optimize asset management by leveraging in-depth asset insights and an enriched CMDB via ready-made integrations to monitor for asset updates, enable SLA compliance, and optimize supply chain management and procurement.
Claroty Secure Remote Access (SRA) enables pharma & biotech plant staff and vendors to access and service OT assets remotely, easily, and securely. SRA also enforces role-based controls and proactive monitoring, among other best practices, minimizing risks posed by remote users.
Complying with recommended standards and required regulations is a notoriously complex, ever-evolving endeavor for pharma & biotech companies. Claroty simplifies compliance not only with respect to cybersecurity but also in adjacent areas — from safety, to sanitation, to quality assurance, to supply chain, and more. Highlights include:
Claroty’s support for the full cyber-physical systems security journey supports and simplifies compliance with the requirements set forth by FSMA, NIS 2.0, RCE, SOCI/SLACIP, FDA cGMPs, and many more.
Compliance with the following recommended practices and standards is enabled by the controls offered by Claroty’s portfolio: CISA CGPs, NIST CSF, ISO 27001, CIS, NIPP, U.S. Bioeconomy Executive Order, and many more.
Seven of the largest 10 pharma & biotech companies worldwide trust Claroty to safeguard their CPS and the availability, integrity, and safety of the products that they provide — and that the health and wellbeing of our society depend on. Here's why:
The Top 3 automation vendors (Rockwell Automation, Schneider Electric, and Siemens) invest in, partner with, and are loyal customers of Claroty, further validating our leadership.
Our comprehensive cybersecurity platform has earned dozens of accolades for seamlessly enhancing the safety, security, and efficiency of OT, IoT, IIoT, BMS, and other CPS.
Our award-winning Team82 researchers have disclosed more vulnerabilities than any other group. Their findings enhance our platform’s protections and drive security industry-wide.
“We needed an OT tool that complements Claroty CTD’s real-time monitoring to reveal the unreachable blind spots in Pfizer’s main manufacturing environments. With Claroty Edge, we attained this faster than ever imagined.”
Jim LaBontyHead of Global Automation Engineering at Pfizer
Claroty's vast technical ecosystem further expands the capabilities — and ROI — of our pharma & biotech industry customers’ existing security and operational investments. Key technical integration partners include:
Claroty xDome is a highly flexible, modular SaaS-based solution that supports your entire industrial cybersecurity journey.
Claroty Secure Remote Access (SRA) delivers frictionless, reliable, and secure remote access for internal and third-party industrial personnel.
Claroty Continuous Threat Detection (CTD) is a robust solution that delivers comprehensive cybersecurity controls for industrial environments.
Want to learn more about how Claroty's portfolio will empower you to achieve cyber and operational resilience?
Enhance network visibility with Claroty's granular intelligence of connected devices used for endpoint profiling through roles and role-mapping rules to create effective enforcement policies, through Aruba's ClearPass Policy Manager.
The Claroty AirWave integration allows Claroty to connect with Aruba AirWave server and import visibility data for wired and wireless devices, that are connected using AirWave infrastructure.
NAC, Network Management
xDome/Medigate/CTD
Visibility & Insights, NSM
Aruba AirWave, Aruba ClearPass Policy Manager
Claroty
The Claroty CTD Connector for AUVESY versiondog fuses CTD’s XIoT visibility with versiondog’s data management capabilities to automate, optimize, and centralize an organization's inventory, risk and vulnerability assessment and correlation, and backup and recovery coverage for OT assets.
Version Management
CTD
CTD
VersionDog
Claroty
Claroty shares device profiles, rule-sets, risk attributes, and application information with Check Point’s IoT Protect SmartConsole for an integrated firewall management experience.
Firewall
xDome/Medigate/CTD
NSM, CTD
Check Point IoT Controller, Checkpoint Management & FW GW
Claroty
To enrich the value of device profiles and their security context, Claroty integrates with numerous Microsoft systems:
Microsoft DHCP enriches Claroty data by adding accurate IP assignment information.
Claroty's integration with Microsoft Intune enriches mobile-managed device profiles with OS, application version, and other security attributes.
Claroty's integration with Microsoft Active Directory brings in data elements that provide additional asset visibility and profiling context.
For patch management, Claroty's integration to Microsoft SCCM improves OS and application visibility for domain attached devices to improve passive vulnerability correlation precision and overall coverage.
Claroty's integration with Microsoft Defender Advanced Threat Protection (MDATP) enables cloud application discovery and is supportive of DLP strategies.
Network Management, DHCP, Mobile Device Management, Patch Management
xDome/Medigate
Vulnerability & Risk Management, Visibility & Insights
Microsoft Active Directory, Microsoft Defender ATP, Microsoft DHCP Server using WinRM, Microsoft Intune, Microsoft SCCM
Claroty
The integrated Claroty and Mission Secure solution enables organizations to gain not only complete visibility into their OT networks, but also the ability to enforce granular, context-aware cybersecurity policies.
Network Security
xDome
Mission Secure Platform
Mission Secure
CTAP Certified
Claroty integrates with the Palo Alto Networks Cortex ecosystem and the Panorama™ firewall solution by fusing its knowledge of device profiles, communication protocols, and workflow requirements, feeding them directly into Panorama to enable an enterprise-class risk management capability.
Firewall, SIEM
xDome/Medigate/CTD
NSM
Palo Alto NGFW
Claroty
The integration with QRadar enables vital communication events, alerts, and vulnerabilities data to flow into QRadar.
SIEM
xDome/Medigate/CTD
Visibility & Insights
QRadar
Claroty
By providing missing device identity and incident context, the integration between Rapid7 and Claroty provides actionable threat intelligence to Rapid7 InsightIDR.
Vulnerability Management
xDome/Medigate
Vulnerability & Risk Management
Rapid7 VM
Claroty
The integration with Rockwell Automation allows Rockwell customers to leverage Claroty's expertise with vulnerabilities, risks, and threat intelligence to enhance Rockwell AssetCentre's data management, centralized inventory, backup, and recovery coverage for the industrial networks.
Version Management
CTD, xDome
Claroty
The integration with Splunk allows it to consume xDome, CTD, and the Medigate Platform’s device profiling, vulnerability, risk insights, advanced traffic monitoring and threat/alert data. The combined solution powers Splunk’s advanced analytics, visualization and reporting capabilities. working with its native OT data model thus enabling advanced investigative detection and response workflows around the XIoT.
SIEM
xDome/Medigate/CTD
Visibility & Insights
Splunk Platform
Claroty
